Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Breast Cancer

Free Subscription Articles published in Gene Retrieve available abstracts of 27 articles: HTML format

Single Articles

June 2025
1. EL-GHALI RM, Daldoul A, Zaied S, Khechine W, et al
   TLR-4 genetic variants as predictive biomarkers for susceptibility and clinical outcomes in triple-negative breast cancer: A case control study.
   Gene. 2025;964:149643.
   PubMed     Abstract available
   
   
   
2. THANKACHAN S, Kavitha KP, Eswaran S, Kabekkodu SP, et al
   Expression of the lncRNA NEAT1/hsa-miR-20b-5p/STAT3 axis in breast cancer.
   Gene. 2025;964:149638.
   PubMed     Abstract available
   
   
   March 2025
3. NOUH WE, El Azab EF, Oraby EA, Ahmed SM, et al
   Genetic variants and breast carcinoma susceptibility: Unveiling the role of MTHFR (rs1801131, rs1801133) and TP53 (rs1042522).
   Gene. 2025;942:149259.
   PubMed     Abstract available
   
   
   
4. HSU CY, Rab SO, Zwamel AH, Oghenemaro EF, et al
   From diagnosis to therapy: The role of LncRNA GAS5 in combatting some cancers affecting women.
   Gene. 2025;941:149217.
   PubMed     Abstract available
   
   
   
5. DOGAN C, Acikbas I, Urganci BE, Azizi Z, et al
   The role of the NEAT1/miR410-3p axis in the invasion of breast cancer cells.
   Gene. 2025 Mar 2:149379. doi: 10.1016/j.gene.2025.149379.
   PubMed     Abstract available
   
   
   February 2025
6. KAZAN HH, Acinan IS, Kandemir B, Karahan CP, et al
   Copy number variations of stepwise-selected doxorubicin-resistant MCF-7 cell lines.
   Gene. 2025;937:149139.
   PubMed     Abstract available
   
   
   
7. SEREJ ZA, Ebrahimi A, Kazemi T, Najafi S, et al
   Retraction notice to "NANOG gene suppression and replacement of let-7 modulate the stemness, invasion, and apoptosis in breast cancer" [GENE 801 (2021) 145844].
   Gene. 2025 Feb 8:149308. doi: 10.1016/j.gene.2025.149308.
   PubMed    
   
   
   January 2025
8. SAADH MJ, Bishoyi AK, Ballal S, Singh A, et al
   MicroRNAs as behind-the-scenes molecules in breast cancer metastasis and their therapeutic role through novel microRNA-based delivery strategies.
   Gene. 2025;944:149272.
   PubMed     Abstract available
   
   
   
9. DU S, Liu J, Ning Y, Yin M, et al
   The piR-31115-PIWIL4 complex promotes the migration of the triple-negative breast cancer cell lineMDA-MB-231 by suppressing HSP90AA1 degradation.
   Gene. 2025 Jan 20:149255. doi: 10.1016/j.gene.2025.149255.
   PubMed     Abstract available
   
   
   
10. WANG G, Wang J, Li C, Mu X, et al
    ZNF703 promotes Triple-Negative breast cancer cell progression and in combination with STK11 predicts disease recurrence (ZS -TNBC Model).
    Gene. 2025;942:149258.
    PubMed     Abstract available
    
    
    
11. STIPP MC, Acco A
    c-Myc-targeted therapy in breast cancer: A review of fundamentals and pharmacological Insights.
    Gene. 2025 Jan 2:149209. doi: 10.1016/j.gene.2024.149209.
    PubMed     Abstract available
    
    
    December 2024
12. WANG Y, Zhang J, Wang Y, Liu Y, et al
    Lower expression of MMP2, FLNA, and CFL1 is correlated with favorable prognosis in invasive micropapillary breast cancer.
    Gene. 2024 Dec 24:149192. doi: 10.1016/j.gene.2024.149192.
    PubMed     Abstract available
    
    
    November 2024
13. LI Y, Gao H
    Investigation and validation of neurotransmitter receptor-related biomarkers for forecasting clinical outcomes and immunotherapeutic efficacy in breast cancer.
    Gene. 2024;937:149135.
    PubMed     Abstract available
    
    
    
14. NIAZMAND A, Nedaeinia R, Vatandoost N, Jafarpour S, et al
    The impacts of dipeptidyl- peptidase 4 (DPP-4) inhibitors on common female malignancies: A systematic review.
    Gene. 2024;927:148659.
    PubMed     Abstract available
    
    
    October 2024
15. TAN SY, Foo CN, Ng FL, Tan CH, et al
    Gene expression Profiling of maslinic Acid-treated MCF-7 breast cancer cells using Nanostring nCounter Pancancer pathway Panel.
    Gene. 2024 Oct 30:149043. doi: 10.1016/j.gene.2024.149043.
    PubMed     Abstract available
    
    
    
16. CHEN S, Liu M, Yi W, Li H, et al
    Micropeptides derived from long non-coding RNAs: Computational analysis and functional roles in breast cancer and other diseases.
    Gene. 2024 Oct 24:149019. doi: 10.1016/j.gene.2024.149019.
    PubMed     Abstract available
    
    
    
17. KONG L, Jin X
    Corrigendum to "Dysregulation of deubiquitination in breast cancer" [Gene (2024) 148175].
    Gene. 2024 Oct 24:149023. doi: 10.1016/j.gene.2024.149023.
    PubMed    
    
    
    
18. WEN P, Jiang D, Qu F, Wang G, et al
    PFDN5 plays a dual role in breast cancer and regulates tumor immune microenvironment: Insights from integrated bioinformatics analysis and experimental validation.
    Gene. 2024;933:149000.
    PubMed     Abstract available
    
    
    August 2024
19. DAI P, Chen Y, Zhang X, Liu L, et al
    MRPL13 is a metastatic and prognostic marker of breast cancer: A silico analysis accompanied with experimental validation.
    Gene. 2024;932:148908.
    PubMed     Abstract available
    
    
    
20. HE X, Huang H, Liu Y, Li H, et al
    Analysis of the function, mechanism and clinical application prospect of TRPS1, a new marker for breast cancer.
    Gene. 2024 Aug 22:148880. doi: 10.1016/j.gene.2024.148880.
    PubMed     Abstract available
    
    
    
21. LAKSHMI S, Priya S
    Molecular insights into epoxyazadiradione induced death in triple-negative breast cancer cells: A system biology approach.
    Gene. 2024 Aug 6:148814. doi: 10.1016/j.gene.2024.148814.
    PubMed     Abstract available
    
    
    July 2024
22. GHALI RM, Zaied S, Daldoul A, Kanabekova P, et al
    Association between Toll-like receptor 2 rs4696483 and rs1898830 polymorphisms and the risk of triple-negative breast cancer.
    Gene. 2024 Jul 17:148773. doi: 10.1016/j.gene.2024.148773.
    PubMed     Abstract available
    
    
    
23. ABDULLAH AR, Gamal El-Din AM, Ismail Y, El-Husseiny AA, et al
    The FSCN1 gene rs2966447 variant is associated with increased serum fascin-1 levels and breast cancer susceptibility.
    Gene. 2024 Jul 2:148743. doi: 10.1016/j.gene.2024.148743.
    PubMed     Abstract available
    
    
    June 2024
24. ALOUFI A, Aubee J, Vargas KM, Apprey V, et al
    Vitamin D receptor polymorphisms and associated miRNAs in the development of breast cancer in African American women.
    Gene. 2024 Jun 28:148695. doi: 10.1016/j.gene.2024.148695.
    PubMed     Abstract available
    
    
    
25. VOSOOGHI R, Motavalizadehkakhky A, Mansouri A, Mehrzad J, et al
    Investigating the effect of hesperetin on estrogen receptor alpha (ERalpha) expression, phosphorylation and activity in MCF-7 cells.
    Gene. 2024;911:148357.
    PubMed     Abstract available
    
    
    April 2024
26. DEHGHANIAN F, Ghahnavieh LE, Nilchi AN, Khalilian S, et al
    Breast cancer drug resistance: Decoding the roles of Hippo pathway crosstalk.
    Gene. 2024;916:148424.
    PubMed     Abstract available
    
    
    March 2024
27. QI Q, Zhu M, Li P, Mi Q, et al
    Systematic analysis of PANoptosis-related genes identifies XIAP as a functional oncogene in breast cancer.
    Gene. 2024 Mar 9:148355. doi: 10.1016/j.gene.2024.148355.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Breast Cancer is free of charge.